4//SEC Filing
Buck Kristen K 4
Accession 0001879231-25-000002
CIK 0000320017other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:09 PM ET
Size
13.7 KB
Accession
0001879231-25-000002
Insider Transaction Report
Form 4
Buck Kristen K
EVP, R&D and CMO
Transactions
- Award
Common Stock
2025-01-09+25,000→ 87,672 total - Tax Payment
Common Stock
2025-01-09$3.80/sh−2,863$10,879→ 82,158 total - Tax Payment
Common Stock
2025-01-09$3.80/sh−2,651$10,074→ 85,021 total - Award
Stock Option (Right to Buy)
2025-01-09+13,000→ 13,000 totalExercise: $3.80From: 2025-01-09Exp: 2035-01-09→ Common Stock (13,000 underlying) - Tax Payment
Common Stock
2025-01-09$3.80/sh−1,908$7,250→ 80,250 total - Tax Payment
Common Stock
2025-01-10$3.73/sh−456$1,701→ 79,794 total
Footnotes (5)
- [F1]Represents 25,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
- [F2]Includes 37,825 unvested restricted stock.
- [F3]Shares withheld as payment of a tax liability on vesting of restricted stock.
- [F4]Includes 36,750 unvested restricted stock.
- [F5]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.
Documents
Issuer
LISATA THERAPEUTICS, INC.
CIK 0000320017
Entity typeother
Related Parties
1- filerCIK 0001879231
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:09 PM ET
- Size
- 13.7 KB